Table 1. Patient clinical and demographic data.
| N=46 | % | |
|---|---|---|
| Age (years), median (min–max) | 64 (37–81) |
|
| Sex | ||
| Male | 41 | 89.1 |
| Female | 5 | 10.9 |
| Performance status | ||
| 0 | 23 | 50.0 |
| 1 | 23 | 50.0 |
| Stage | ||
| IIIB | 2 | 4.3 |
| IV | 44 | 95.7 |
| Histology | ||
| Squamous | 13 | 28.3 |
| Adenocarcinoma | 25 | 54.3 |
| Large cell | 1 | 2.2 |
| Undifferentiated | 7 | 15.2 |
| Smoking status | ||
| Non-smoker | 5 | 10.9 |
| Former smoker | 24 | 52.2 |
| Active smoker | 17 | 37.0 |
| Baseline brain metastases | 7 | 15.2 |
| Prior surgery | 10 | 21.7 |
| Prior definitive radiation | 13 | 28.3 |
| Prior palliative radiation | 6 | 13.0 |
| Line therapy | ||
| Second line | 8 | 17.4 |
| Third line | 38 | 82.6 |
| Line received docetaxel | ||
| First line | 24 | 52.2 |
| Second line | 22 | 47.8 |